About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

2019 Annual General Meeting Results

May 22, 2019August 28, 2019

Click here to read more

Post navigation

Phosphagenics and Mylan Agree Settlement

Change of Company Name and ASX Code

Related Posts

Appendix 3X Notices – Three New Directors

April 22, 2015

Phosphagenics Receives Arbitration Update from SIAC

September 4, 2018

MEDIA | The Pharma Letter

March 4, 2025March 24, 2025

Recent Posts

Euroz Hartleys | Successful Phase 3 Interim Results
July 8, 2026
Avecho Phase III insomnia trial advances following positive interim analysis
June 24, 2026
Euroz Hartleys Initiates Research Coverage
May 21, 2026

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.